— Know what they know.
Not Investment Advice

NCNA NASDAQ

NuCana plc
1W: -14.8% 1M: -21.6% 3M: -21.6% YTD: -70.0% 1Y: -77.6% 3Y: -100.0% 5Y: -100.0%
$1.09
-0.08 (-6.84%)
 
Weekly Expected Move ±10.3%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $6.6M mcap · 6M float · 1.25% daily turnover · Short 46% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$268K +0.0% ▲
Operating Income
-$20M +10.7% ▲
Net Income
-$29M -51.1% ▼
EPS (Diluted)
$-7.75 -137.1% ▼
EBITDA
-$20M +10.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$268K
Gross Profit$0$0$0$0-$268K
Gross Margin—————
R&D Expenses$37M$36M$25M$18M$0
SG&A Expenses$9M$7M$6M$5M$8M
Operating Expenses$45M$44M$31M$23M$20M
Operating Income-$45M-$44M-$33M-$23M-$20M
Operating Margin—————
Interest Expense$0$0$1M$0$20K
Income Before Tax-$48M-$38M-$32M-$22M-$30M
Tax Expense-$7M-$6M-$4M-$3M-$1M
Net Income-$41M-$32M-$28M-$19M-$29M
Net Margin—————
EPS (Diluted)$-9.75$-6.12$-5.25$-3.27$-7.75
EBITDA-$42M-$52M-$32M-$22M-$20M
Shares Outstanding4M5M5M6M4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms